Atlas Trials

Study of Ketamine for Depression in Cancer Patients Receiving Palliative Care

Clinical trial NCT03410446 · COMPLETED

Trial details

NCT number
NCT03410446
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
DepressionCancerPalliative Care
Start date
2018-07-16
Primary completion
2021-11-27
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.